198 related articles for article (PubMed ID: 15541106)
1. The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA.
Stamey TA
BJU Int; 2004 Nov; 94(7):963-4. PubMed ID: 15541106
[No Abstract] [Full Text] [Related]
2. The distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening.
Porter MP; Stanford JL; Lange PH
Prostate; 2006 Jul; 66(10):1044-51. PubMed ID: 16598738
[TBL] [Abstract][Full Text] [Related]
3. Detection rate of prostate cancer on biopsy according to serum prostate-specific antigen in Korean men: a multicenter study.
Yang WJ; Lee DH; Chung BH; Cho JS; Choi YD; Kim SJ; Cho IR; Kim HS; Kim CI; Hong SJ;
Urology; 2006 Feb; 67(2):333-6. PubMed ID: 16461083
[TBL] [Abstract][Full Text] [Related]
4. The performance of prostate specific antigen, prostate specific antigen density and transition zone density in the era of extended biopsy schemes.
Elliott CS; Shinghal R; Presti JC
J Urol; 2008 May; 179(5):1756-61; discussion 1761. PubMed ID: 18343425
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant?
Gosselaar C; Roobol MJ; Schröder FH
BJU Int; 2005 Feb; 95(2):231-7. PubMed ID: 15667646
[TBL] [Abstract][Full Text] [Related]
6. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
[TBL] [Abstract][Full Text] [Related]
7. [Screening for prostatic cancer].
Pushkar' DIu; Govorov AV; Bormotin AV
Urologiia; 2003; (1):10-5. PubMed ID: 12621959
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
Fitzpatrick JM; Banu E; Oudard S
BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674
[TBL] [Abstract][Full Text] [Related]
9. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
[TBL] [Abstract][Full Text] [Related]
10. [Prostatic punch biopsy].
Braun M; Engelmann U
Aktuelle Urol; 2006 Jul; 37(4):291-302. PubMed ID: 16897646
[No Abstract] [Full Text] [Related]
11. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
Shao Q; Song J; Zhou ZJ; Du LD
Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
[TBL] [Abstract][Full Text] [Related]
12. [The usefulness of percentage of free prostate specific antigen/prostate specific antigen density in the diagnosis of prostate cancer].
Han G; Gao JP; Cao XL; Hong BF; Tang J
Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):379-81. PubMed ID: 16638346
[TBL] [Abstract][Full Text] [Related]
13. Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen and digital rectal examination.
Tsuzuki T; Hernandez DJ; Aydin H; Trock B; Walsh PC; Epstein JI
J Urol; 2005 Feb; 173(2):450-3. PubMed ID: 15643200
[TBL] [Abstract][Full Text] [Related]
14. Outcome for repeated biopsy of the prostate: roles of serum PSA, small atypical glands, and prostatic intraepithelial neoplasia.
Brimo F; Vollmer RT; Corcos J; Humphrey PA; Bismar TA
Am J Clin Pathol; 2007 Oct; 128(4):648-51. PubMed ID: 17875517
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
Konety BR; Bird VY; Deorah S; Dahmoush L
J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
[TBL] [Abstract][Full Text] [Related]
16. [Predictive value of serum PSA in detection of prostate cancer by fine needle biopsy].
Pozharisskiĭ KM; Arzumanov AA; Kudaĭbergenova AG; Ovchinnikov IV; Leonenkov RV
Vopr Onkol; 2008; 54(3):324-7. PubMed ID: 18652237
[TBL] [Abstract][Full Text] [Related]
17. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
18. Re: Billis et al.: Does the type of prostatic atrophy influence the association of extent of atrophy in needle biopsies and serum prostate-specific antigen levels? (Urology 2009;74:1111-1115).
Papatsoris A; Albanis S; Deliveliotis C
Urology; 2010 May; 75(5):1239; author reply 1240. PubMed ID: 20451754
[No Abstract] [Full Text] [Related]
19. Measurement of prostate specific antigen complexed to alpha1-antichymotrypsin to avoid unnecessary biopsy in patients with serum prostate specific antigen levels 4-20 ng/mL.
Nakano Y; Okamura K; Takamura S; Okamoto N; Narishima M; Yoshino Y; Hattori R; Ono Y; Ohshima S; Nagasaka T
Int J Urol; 2005 Aug; 12(8):721-7. PubMed ID: 16174045
[TBL] [Abstract][Full Text] [Related]
20. Verification bias and the prostate-specific antigen test--is there a case for a lower threshold for biopsy?
Schröder FH; Kranse R
N Engl J Med; 2003 Jul; 349(4):393-5. PubMed ID: 12878747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
